Live Antabax Import data of Philippines imports from malaysia under HS Code 330790 via Port Manila-int'l-container-port , our Philippines customs import data reports include date, value, quantity, product description, HS code, port, country, and Philippines antabax importers data
| Date |
HS Code |
Product Description |
Origin Country |
Custom Name |
QTY. |
Unit |
Weight |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-11-07 00:00:00 |
33079030000
|
ANTABAX WIPES | MALAYSIA | Manila Int'l Container Port | 629 | Kilogram | 1261.34 | Importer Name |
| 2024-11-29 00:00:00 |
33079030000
|
ANTABAX WIPES | MALAYSIA | Manila Int'l Container Port | 555 | Kilogram | 1118.66 | Importer Name |
2024-11-07 00:00:00
ANTABAX WIPES
629
Kilogram
1261.34
2024-11-29 00:00:00
ANTABAX WIPES
555
Kilogram
1118.66
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 330790 for Philippines antabax imports from Thailand via Port Manila-int'l-container-port.
Port Manila-int'l-container-port typically refers to a port that is used for handling and forwarding shipments into Philippines, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for antabax products, enabling better decision-making for trade and market expansion for Philippines antabax imports from malaysia under HS code 330790 via Port Manila-int'l-container-port.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the antabax market.
